Springdale Rotary club will hear from Kevin Clark from NOWDiagnostics. Kevin Clark has 30 years’ experience in the healthcare industry, creating diagnostic companies from inception to lucrative exit. His extensive career includes the development of a diagnostics company and the sale of that company to one of the largest life sciences companies in the world. He took the company public, managed multinational operations and brokered mergers and acquisitions, all while developing, manufacturing and selling products that required FDA approval. He has successfully ushered 126 products through the FDA approval process.
As CEO of NOWDiagnostics Inc., Clark is responsible for the approval and commercialization of seven products globally. NOWDiagnostics Inc. has created a GMP certified, state-of-the-art facility and has offices in three countries. They currently have over 35 different products in the R&D pipeline and continue to pursue their purpose of empowering patients and caregivers with the knowledge necessary to make intelligent healthcare choices.
As CEO of ERBA Diagnostics, Clark brought the company to profitability following losses in nine consecutive quarters. Among his accomplishments was the sale of controlling interest of IVAX Diagnostics (now known as ERBA Diagnostics) to TransAsia Bio-Medicals, the largest diagnostics company in India. As CEO, 200% revenue growth was achieved. He consummated private investment of public equity (PIPE) of $30 million in common stock and warrants to grow ERBA Diagnostics through mergers and acquisitions. He managed facilities across the U.S. and internationally in England, the Czech Republic, Italy, Russia, Brazil, and France. More than 200 types of tests for antibodies and antigens for use in medical devices were sold.
He served six years as COO of IVAX Diagnostics, the parent company of ImmunoVision, Inc., which he founded in 1987 and sold to IVAX Corporation in 1995. During his 18 years at ImmunoVision/IVAX Diagnostics, he was directly responsible for the successful development and clinical trials of 18 diagnostic test kits.
Previously, Clark served as Executive VP and Founding Member of the Arkansas Biotechnology Association and has also served on the Board for the University of Arkansas Technology Development Foundation and Arkansas BioVentures.